Clin2
NCT07239115Likely a fitRecruiting

Levetiracetam to prevent seizures after brain tumor surgery

Postoperative Seizures After Brain Tumor Surgery

Treatments studied

Part of Brain & nervous system, Cancer clinical trials.

This trial tests whether the drug levetiracetam can prevent seizures in people who have brain tumor surgery. If you are having surgery to remove a brain tumor and have never had a seizure, this study may help keep you from having one after the operation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
558 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You are scheduled for surgery to remove a brain tumor located above the back of the head (supratentorial).
  • You have never had a seizure or epilepsy before.
  • You have not taken any seizure medication before.
  • You are generally functioning well (Karnofsky score of 70 or higher).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07758062Not yet recruiting· Phase 2
Levetiracetam with standard chemo-radiation for hypoxic glioblastoma

This trial tests whether adding an extended-release seizure medication (levetiracetam) to the standard treatment plan (surgery followed by radiation and chemotherapy) can improve outcomes for people with a specific type of brain tumor called glioblastoma, especially when the tumor shows signs of low oxygen levels (hypoxia).

Tianjin, Tianjin Municipality
NCT05897658Not yet recruiting· Phase 3
Levetiracetam to prevent seizures after brain tumor surgery

This trial tests whether taking levetiracetam (a medicine used to prevent seizures) around the time of brain tumor surgery can reduce the chance of postoperative seizures. It may help people who are having surgery in the brain area where seizures are a known risk.

NCT06442748Recruiting· Phase 3
Short vs long seizure medicine in brain tumor patients

This study compares stopping seizure medicine (levetiracetam) after 6 months versus continuing it longer for people with primary brain tumors. It aims to find out if it is safe to stop the medication sooner and may help you avoid long-term side effects.

Udupi, Karnataka
NCT07130786Recruiting· Phase 2
Preventing seizures with medication for brain tumors in movement area

This study tests whether giving a seizure medication (levetiracetam) to people with brain tumors in the movement area can prevent seizures. It compares taking the medication to not taking it, starting before any seizure occurs.

Boston, Massachusetts
NCT03048084Recruiting· Phase 4
Testing seizure medicines after a first seizure in brain tumors

This trial studies which seizure medicine works best for adults who recently had their first seizure caused by certain brain tumors. It may help reduce seizures and improve daily functioning while choosing the right medicine after the first episode.

Amsterdam
NCT06866691Recruiting· Phase 4
Seizure prevention after traumatic brain injury

This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.

Winston-Salem, North Carolina

Hear when a new Postoperative Seizures After Brain Tumor Surgery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.